Home / World / A Clinical Trial Of ‘Effective’ Chinese Herbal Medicine To Treat Covid-19 Underway
Clinical trial of ‘effective’ Chinese herbal medicine to treat Covid-19 under way

A Clinical Trial Of ‘Effective’ Chinese Herbal Medicine To Treat Covid-19 Underway

KARACHI – A research centre at the University of Karachi (KU) in collaboration with Indus Hospital (IH) recently started a clinical trial of a traditional Chinese drug to treat mild cases of Covid-19, Dawn news reported Monday.
According to researchers at KU’s Dr Panjwani Center for Molecular Medicine and Drug Research, the trial will test the efficacy and safe use of Jinhua Qinggan Granule – a combination of natural herbs widely used during the Covid-19 outbreak in China.
It consists of 12 herbal components, including honeysuckle, mint and liquorice.
“The drug tested in China has curative and preventive effects. It is one of the drugs most recommended in China’s national guidelines against Covid-19,” said study principal investigator Professor Raza Shah, adding that the drug had so far been administered to 15 patients with Covid-19 in Karachi.
Asked about the reason for testing the drug only for mild cases, Shah said it was the first such trial in Pakistan to be conducted under an international protocol.
“We also exclude patients with other health complications to minimize the risk of an adverse reaction with other drugs.”
As part of the partnership with IH, 300 patients able to adhere to the principles of home isolation would participate in the trial.
Laboratory samples from patients would be tested at the KU facility while patient registration would be done at the hospital, which would also offer its intensive care units if required.
According to the researchers, compliance with the drug regimen would be ensured by maintaining regular contact with patients. The trial will likely be completed in four to five months.
Citing studies in China, they said the drug has a curative effect in treating mild and moderate patients and may also improve the rate of recovery of lymphocytes and white blood cells, in addition to reducing the rate of deterioration of the condition of patients.
A comparative experiment, they said, showed that patients who took Jinhua Qinggan Granule tested negative for the coronavirus two and a half days earlier than a group who did not take the granule. The group treated with the granule also took eight days to show improvement, while the other group took 10.3 days.
Dr. Naila Baig Ansari, representing the Indus hospital, said: “The drug available in over-the-counter sachets in China was developed during the H1N1 flu pandemic of 2009. It has shown its effectiveness against Covid-19.”
Professor M. Iqbal Chaudhary, director of the International Center for Chemical and Biological Sciences (ICCBS), said the trial had been approved by the National Bioethics Committee and the Drug Regulatory Authority of Pakistan and that a license for conduct the test had been obtained.
“The fact that the trial is for mild cases does not diminish its importance. Not all mild cases of Covid-19 will cure. Therefore, we must test its effectiveness in our population.”
Professor Chaudhry described the clinical trial as a welcome sign for the country and said it would directly benefit Pakistan, as the studies would help make drugs available at low cost and strengthen the country’s research capacity.
(Sahar News Monitoring Desk)

Check Also

Iran Ready to Sign Military and Security Agreements with Gulf States

Iran Ready to Sign Military and Security Agreements with Gulf States

TEHRAN – Iranian Defense Minister, Amir Hatami, has said that Iran is ready to sign …

Leave a Reply

Your email address will not be published. Required fields are marked *